Brandi Carroll-Chechak
Family · Hermitage, PANPI 1235507294
Payments from drug & device makers
Across 180 payments — averaging $18.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$724
- AstraZeneca$285
- Johnson & Johnson$283
- Amgen$254
- AbbVie$222
- Lilly USA, LLC$203
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,249100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 41 | $724 |
| AstraZeneca | 13 | $285 |
| Johnson & Johnson | 12 | $283 |
| Amgen | 16 | $254 |
| AbbVie | 11 | $222 |
| Lilly USA, LLC | 11 | $203 |
| Pfizer | 12 | $196 |
| Exact Sciences | 8 | $159 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $152 |
| Teva Pharmaceuticals USA, Inc. | 8 | $125 |
| Bayer | 8 | $121 |
| Harmony Biosciences LLC | 6 | $112 |
| Biohaven Pharmaceuticals, Inc. | 6 | $98 |
| Boehringer Ingelheim | 5 | $73 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $59 |
| Amarin Pharma, Inc. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Mylan Specialty L.p. | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
| Optinose US, Inc. | 1 | $14 |
How this compares
$3,249 in reported general payments places this provider in the 90th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 16 | $20,481 |
| TradjentaLinagliptin | 17 | $11,220 |
| PaxlovidNirmatrelvir/Ritonavir | 11 | $1,413 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 38 | $980 |
| Metoprolol Succinate | 13 | $585 |
| Methylprednisolone | 91 | $565 |
| Levothyroxine Sodium | 33 | $357 |
| Pantoprazole Sodium | 29 | $308 |
| Lisinopril | 43 | $257 |
| Alprazolam | 55 | $237 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $226 |
| Fluticasone Propionate | 43 | $171 |
| Doxycycline Monohydrate | 36 | $168 |
| Lorazepam | 29 | $164 |
| Tramadol Hcl | 43 | $157 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimTradjenta | $73 | $11,22017 claims |
| PfizerPaxlovid | $196 | $1,41311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,717 family providers in Pennsylvania.
Other family in Hermitage
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.